ArticleInternational journal of cardiology. Cardiovascular risk and prevention2025
Regional and demographic variations in diabetes mellitus and myocardial infarction mortality among US adults: A retrospective observational analysis from 1999 to 2023.
Article in International journal of cardiology. Cardiovascular risk and prevention, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Once-Weekly Insulin Efsitora Alfa Versus Once Daily Insulin in Patients With Type 2 Diabetes: A Systematic Review and Meta-Analysis.Endocrinology, diabetes & metabolism · 2025Pooled it
- Depression, health anxiety, and five-year mortality after ST-elevation myocardial infarction: the SEMI-CI cohort.International journal of cardiology. Cardiovascular risk and prevention · 2026Article
- Evaluation of the 2021-2024 Implementation of the Fresh Start Enhanced Food Is Medicine Intervention Among Rural, Underinsured People With Type 2 Diabetes.Preventing chronic disease · 2026Article
- Impact of β-blocker therapy after acute myocardial infarction in patients with preserved ejection fraction: a meta-analysis.Archives of medical sciences. Atherosclerotic diseases · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Individuals with diabetes mellitus (DM) are at an increased risk of having myocardial infarction (MI). We aim to identify the trends in the mortality rates from DM and MI among US adults stratified by demographic and geographical parameters. Methods: The CDC-WONDER database was used to extract death certificate data for adults aged ≥25 years. Crude mortality rates (CMR) and age-adjusted mortality rates (AAMRs) per 100,000 persons were calculated, and temporal trends were identified by calculating annual percent change (APC) using JoinPoint regression analysis. Results: From 1999 to 2023, a total of 712,921 DM and MI-related deaths were reported among adults in the United States. The AAMR significantly declined from 18.99 in 1999 to 10.20 in 2018 Following this, the AAMR rose to 12.27 in 2021, with an APC of 7.2 (95 % CI: 4.7 to 8.9). This was followed by a decline in AAMR to the pre-pandemic levels (AAMR: 9.6 in 2023). The AAMR for males was considerably higher compared to women throughout the study period (16.5 vs. 10.2). Non-Hispanic Black or African American people had the highest AAMR (19.5), followed by Hispanic or Latino people (15.3), NH white people (12.5), and NH other populations (11.2). Southern region and rural areas experienced higher mortality rates compared to urban areas. Conclusion: We observed decreasing trends in DM and myocardial infarction-related deaths throughout the study period, however, a surge was noted during the COVID-19 pandemic. Mortality is higher among men, NH black populations, and rural areas.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.